John G Ullman & Associates Inc Quidel Ortho Corp Transaction History

John G Ullman & Associates Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$58.16 - $75.44 $1.66 Million - $2.15 Million	-28,550 Reduced 71.11%	11,600 $854,000
Q3 2023 Nov 01, 2023	BUY	$70.9 - $88.63 $568,547 - $710,723	8,019 Added 24.96%	40,150 $2.93 Million
Q2 2023 Aug 21, 2023	BUY	$81.09 - $94.16 $36,490 - $42,372	450 Added 1.42%	32,131 $2.66 Million
Q1 2023 May 05, 2023	BUY	$82.98 - $91.46 $385,857 - $425,289	4,650 Added 17.2%	31,681 $2.82 Million
Q4 2022 Feb 08, 2023	BUY	$66.93 - $97.5 $106,017 - $154,440	1,584 Added 6.22%	27,031 $2.32 Million
Q3 2022 Oct 19, 2022	BUY	$69.86 - $107.63 $1.26 Million - $1.94 Million	17,990 Added 241.25%	25,447 $1.82 Million
Q2 2022 Jul 27, 2022	BUY	$89.06 - $117.64 $664,120 - $877,241	7,457 New	7,457 $725,000

291

67.5M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.98B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on John G Ullman & Associates Inc with notifications on news.